KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Current Deferred Revenue (2016 - 2025)

Elevance Health (ELV) has disclosed Current Deferred Revenue for 17 consecutive years, with $1.5 billion as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue fell 0.99% to $1.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 billion through Dec 2025, down 0.99% year-over-year, with the annual reading at $1.5 billion for FY2025, 0.99% down from the prior year.
  • Current Deferred Revenue for Q4 2025 was $1.5 billion at Elevance Health, down from $1.8 billion in the prior quarter.
  • The five-year high for Current Deferred Revenue was $4.5 billion in Q2 2023, with the low at $954.0 million in Q3 2021.
  • Average Current Deferred Revenue over 5 years is $1.9 billion, with a median of $1.5 billion recorded in 2024.
  • The sharpest move saw Current Deferred Revenue skyrocketed 359.11% in 2023, then tumbled 66.78% in 2024.
  • Over 5 years, Current Deferred Revenue stood at $1.2 billion in 2021, then dropped by 3.56% to $1.1 billion in 2022, then grew by 26.08% to $1.4 billion in 2023, then increased by 7.56% to $1.5 billion in 2024, then dropped by 0.99% to $1.5 billion in 2025.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $1.5 billion, $1.8 billion, and $1.6 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.